JP2021532163A5 - - Google Patents
Info
- Publication number
- JP2021532163A5 JP2021532163A5 JP2021506399A JP2021506399A JP2021532163A5 JP 2021532163 A5 JP2021532163 A5 JP 2021532163A5 JP 2021506399 A JP2021506399 A JP 2021506399A JP 2021506399 A JP2021506399 A JP 2021506399A JP 2021532163 A5 JP2021532163 A5 JP 2021532163A5
- Authority
- JP
- Japan
- Prior art keywords
- body according
- delivery body
- silica particles
- porous silica
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862714874P | 2018-08-06 | 2018-08-06 | |
| US62/714,874 | 2018-08-06 | ||
| KR10-2019-0065620 | 2019-06-03 | ||
| PCT/KR2019/006682 WO2020032366A1 (ko) | 2018-08-06 | 2019-06-03 | 면역반응 물질 전달체 |
| KR1020190065620A KR102316722B1 (ko) | 2018-08-06 | 2019-06-03 | 면역반응 물질 전달체 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532163A JP2021532163A (ja) | 2021-11-25 |
| JP2021532163A5 true JP2021532163A5 (enExample) | 2022-02-02 |
| JP7688394B2 JP7688394B2 (ja) | 2025-06-04 |
Family
ID=69670782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506399A Active JP7688394B2 (ja) | 2018-08-06 | 2019-06-03 | 免疫反応物質送達体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12343406B2 (enExample) |
| EP (1) | EP3834820A4 (enExample) |
| JP (1) | JP7688394B2 (enExample) |
| KR (1) | KR102316722B1 (enExample) |
| CN (1) | CN112543631B (enExample) |
| AU (3) | AU2019317939A1 (enExample) |
| CA (1) | CA3108251C (enExample) |
| SG (1) | SG11202101258VA (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114113603B (zh) * | 2021-06-30 | 2023-11-17 | 四川大学华西医院 | Cytl1作为胃癌预后标志物的应用 |
| CN113769099A (zh) * | 2021-09-30 | 2021-12-10 | 佛山病原微生物研究院 | 一种asb17在制备traf6相关炎症性疾病药物中的用途 |
| CN114558147A (zh) * | 2022-03-14 | 2022-05-31 | 中国人民解放军空军军医大学 | 基于x射线激发的化疗-免疫疗法-光动力学三位一体联合治疗肿瘤的新型药物递送系统 |
| CN117607461A (zh) * | 2023-12-06 | 2024-02-27 | 陕西省动物研究所 | 一种s100a8蛋白的检测方法及其应用 |
| CN120131968B (zh) * | 2025-05-14 | 2025-07-29 | 广州医科大学附属第二医院 | Trim3基因和/或其表达产物在制备治疗骨质疏松症的药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5202857B2 (ja) * | 2007-03-13 | 2013-06-05 | 古河電気工業株式会社 | 分散性が高く、非特異的吸着を防止した複合粒子、複合粒子コロイド、それを用いた分析試薬、及び複合粒子の製造方法 |
| US20110300186A1 (en) * | 2010-04-14 | 2011-12-08 | Battelle Memorial Institute | Functionalized Nano- and Micro-materials for Medical Therapies |
| AU2012323937A1 (en) * | 2011-10-14 | 2014-06-05 | Stc.Unm | Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| CN104136370B (zh) | 2012-02-29 | 2016-06-15 | 日产化学工业株式会社 | 有机溶剂分散二氧化硅溶胶和有机溶剂分散二氧化硅溶胶的制造方法 |
| JP5621950B2 (ja) | 2012-10-10 | 2014-11-12 | Dic株式会社 | 有機無機複合シリカナノ粒子及びそれを有する分散液、並びにそれらの製造方法 |
| US11786469B2 (en) * | 2014-07-22 | 2023-10-17 | Cheolhee WON | Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome |
| JP5789335B1 (ja) | 2014-09-08 | 2015-10-07 | 明成化学工業株式会社 | 分散剤及び分散組成物 |
| JP6868862B2 (ja) * | 2015-08-31 | 2021-05-12 | 国立研究開発法人産業技術総合研究所 | メソポーラスシリカ粒子 |
| KR101924519B1 (ko) | 2016-06-08 | 2018-12-04 | 광주과학기술원 | 펩타이드-키토산 개질 나노입자 및 이를 포함하는 약물 전달체 |
| US11129796B2 (en) * | 2017-02-06 | 2021-09-28 | Lemonex Inc. | Physiologically active substance carrier |
| WO2019022521A2 (ko) * | 2017-07-25 | 2019-01-31 | 주식회사 레모넥스 | 혈관 내 생리활성물질 전달용 조성물 |
| KR102152348B1 (ko) * | 2017-09-05 | 2020-09-08 | 주식회사 레모넥스 | 세포 운명 조절용 조성물 |
-
2019
- 2019-06-03 US US17/265,692 patent/US12343406B2/en active Active
- 2019-06-03 EP EP19846510.6A patent/EP3834820A4/en active Pending
- 2019-06-03 JP JP2021506399A patent/JP7688394B2/ja active Active
- 2019-06-03 SG SG11202101258VA patent/SG11202101258VA/en unknown
- 2019-06-03 CA CA3108251A patent/CA3108251C/en active Active
- 2019-06-03 CN CN201980052469.0A patent/CN112543631B/zh active Active
- 2019-06-03 KR KR1020190065620A patent/KR102316722B1/ko active Active
- 2019-06-03 AU AU2019317939A patent/AU2019317939A1/en not_active Abandoned
-
2023
- 2023-07-25 AU AU2023208105A patent/AU2023208105A1/en not_active Abandoned
-
2025
- 2025-09-04 AU AU2025226757A patent/AU2025226757A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019502379A5 (enExample) | ||
| JP2021118723A5 (enExample) | ||
| JP2020528758A5 (enExample) | ||
| ES2735354T3 (es) | Métodos para aumentar la pureza de proteínas utilizando la cromatografía basada en proteína A | |
| JP2021519089A5 (enExample) | ||
| US20110256184A1 (en) | Non-ordered Mesoporous Silica Structure for Biomolecule Loading and Release | |
| JP2019508017A5 (enExample) | ||
| JP2019534036A5 (enExample) | ||
| JP2019500012A5 (enExample) | ||
| JP2021502964A5 (enExample) | ||
| JP2018521959A5 (enExample) | ||
| GB2616128A (en) | Antibody molecules that bind to NKp30 and uses thereof | |
| JP2023539645A5 (enExample) | ||
| RU2015128651A (ru) | Способ продуцирования белка | |
| JP2024521405A5 (enExample) | ||
| CA3108251C (en) | Immunoreactant carrier | |
| WO2018089829A1 (en) | Cd46-specific effector cells and uses thereof | |
| JP2023527531A5 (enExample) | ||
| CN114262382A (zh) | 双特异性抗体及其应用 | |
| JP7012023B2 (ja) | タンパク質精製方法 | |
| US20240352084A1 (en) | Therapeutic muteins | |
| Chen et al. | Signaling molecules in the microenvironment of hepatocellular carcinoma | |
| JP6823596B2 (ja) | アニオン性ポリマーによる抗体を含有する組成物の精製方法 | |
| CN115942975A (zh) | 白细胞介素-1受体辅助蛋白的特异性结合域和嵌合抗原受体 | |
| JP2026066976A (ja) | モジュラー合成受容体及びその使用方法 |